Home | Publications | Treatments | Smoking cessation place holder
place holder place holder

Smoking cessation

NRT Smoking Cessation Aids in the United Kingdom


Publication Date   August 2006
Publisher   Euromonitor International
Product Type  
Pages   40
ISBN Number   not applicable
Product Code   EUR656
Ask a question about this product?

Price £450.00

approximately: $671 | €536

Summary


This Smoking Cessation Aids in the UK report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2000-2005), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2010 illustrate how the market is set to change.

Product coverage: NRT gum, NRT patches, NRT inhalators, other

Data coverage: market sizes (historic and forecasts), company shares, brand shares

Why buy this report?

  • Get a detailed picture of the smoking cessation aids industry
  • Pinpoint growth sectors and trends and identify factors driving change
  • Understand the competitive environment, the market's major players and leading brands
  • Use five-year forecasts to assess how the market is predicted to develop

Content


NRT Smoking Cessation Aids in the United Kingdom

1. EXECUTIVE SUMMARY

2. OPERATING ENVIRONMENT

2.1 OTC Registration and Classification
2.2 Vitamins and Dietary Supplements Registration and Classification
2.3 Advertising
2.4 Packaging and Labelling
2.5 Distribution
2.6 De-listing or De-reimbursement
2.7 Traditional Remedies
2.8 Homoeopathy
Table 1 Retail Sales of Homoeopathy 1998-2005
2.9 Generics
2.10 Consumer Expenditure on Health Goods and Medical Services
Table 2 Consumer Expenditure on Health Goods and Medical Services 2000-2005
2.11 Life Expectancy
Table 3 Life Expectancy at Birth 2000-2005

3. OTC HEALTHCARE SALES

3.1 Market Performance
Table 4 Sales of OTC Healthcare by Sector: Value 2000-2005
Table 5 Sales of OTC Healthcare by Sector: % Value Growth 2000-2005
3.2 Switches
Summary 1 OTC Healthcare Switches 2004-2005
3.3 Key Trends and Developments
3.4 Competitive Environment
Table 6 OTC Healthcare Company Shares by Retail Value 2001-2005
Table 7 OTC Healthcare Brand Shares by Retail Value 2002-2005
3.5 Leading Company Profile: Bayer Plc
Summary 2 Bayer Plc: Operational Indicators 2004
Table 8 Bayer Plc: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.6 Leading Company Profile: Boots Healthcare International
Summary 3 Boots Healthcare International: Operational Indicators 2005
Table 9 The Boots Co Plc: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.7 Leading Company Profile: GlaxoSmithKline Plc
Summary 4 GlaxoSmithKline Plc: Operational Indicators 2005
Table 10 GlaxoSmithKline Plc: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.8 Leading Company Profile: Johnson & Johnson MSD Ltd
Summary 5 Johnson & Johnson MSD Ltd: Operational Indicators 2004
Table 11 Johnson & Johnson MSD Ltd: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.9 Leading Company Profile: Novartis Pharmaceuticals UK Ltd
Summary 6 Novartis AG: Operational Indicators 2004
Table 12 Novartis Pharmaceuticals UK Ltd: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.10 Leading Company Profile: Pfizer Consumer Healthcare Ltd
Summary 7 Pfizer Inc: Operational Indicators 2004
Table 13 Pfizer Consumer Healthcare Ltd: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.11 Leading Company Profile: Reckitt Benckiser Plc
Summary 8 Reckitt Benckiser Plc: Operational Indicators 2004
Table 14 Reckitt Benckiser Plc: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.12 Leading Company Profile: Roche Products Ltd
Summary 9 Roche Products Ltd: Operational Indicators 2004
Table 15 Roche Products Ltd: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.13 Leading Company Profile: Seven Seas Ltd
Summary 10 Seven Seas Ltd: Operational Indicators 2004
Table 16 Seven Seas Ltd: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.14 Leading Company Profile: SSL International Plc
Summary 11 SSL International Plc: Operational Indicators 2005
Table 17 SSL International Plc: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.15 Leading Company Profile: Wyeth Consumer Healthcare
Summary 12 Wyeth Consumer Healthcare: Operational Indicators 2005
Table 18 Wyeth Consumer Healthcare: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.16 Emerging and Niche Companies
3.17 Retail Distribution
Table 19 Sales of OTC Healthcare by Distribution Format: % Analysis 2000/2005
Table 20 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2005
3.18 Retailer Activity and Private Label Trends
Table 21 Penetration of Private Label by Sector 2001-2005
3.19 Forecast Market Performance
Table 22 Forecast Sales of OTC Healthcare by Sector: Value 2005-2010
Table 23 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2005-2010

4. NRT SMOKING CESSATION AIDS SALES

4.1 Number of Smokers
Table 24 Number of Smokers by Gender 2000-2005
4.2 Sector Performance
Table 25 Sales of NRT Smoking Cessation Aids by Subsector: Value 2000-2005
Table 26 Sales of NRT Smoking Cessation Aids by Subsector: % Value Growth 2000-2005
Table 27 NRT Smoking Cessation Aids Company Shares by Retail Value 2001-2005
Table 28 NRT Smoking Cessation Aids Brand Shares by Retail Value 2002-2005
Table 29 Forecast Sales of NRT Smoking Cessation Aids by Subsector: Value 2005-2010
Table 30 Forecast Sales of NRT Smoking Cessation Aids by Subsector: % Value Growth 2005-2010
4.3 New Product Developments
Summary 13 NRT Smoking Cessation Aids: New Product Launches 2005

5. DEFINITIONS